ICMR should lead high quality research on vaccine safety, desist from academic censorship – an open letter
"ICMR must lead the country in giving vaccine safety its due priority. It must publish data from the original phase-3 trial with long-term follow-up, as well as lead other high quality research studies on long-term safety."
Author: UHO
Disclaimer: link
Conflict of interest:None